BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37673491)

  • 1. Significance of Kidney Disease in Cardiovascular Disease Patients.
    Mehta A; Chandiramani R; Spirito A; Vogel B; Mehran R
    Interv Cardiol Clin; 2023 Oct; 12(4):453-467. PubMed ID: 37673491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiorenal Nexus: A Review With Focus on Combined Chronic Heart and Kidney Failure, and Insights From Recent Clinical Trials.
    McCullough PA; Amin A; Pantalone KM; Ronco C
    J Am Heart Assoc; 2022 Jun; 11(11):e024139. PubMed ID: 35616212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiorenal Syndrome: An Important Subject in Nephrocardiology.
    Hatamizadeh P
    Cardiol Clin; 2021 Aug; 39(3):455-469. PubMed ID: 34247758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options.
    Jankowski J; Floege J; Fliser D; Böhm M; Marx N
    Circulation; 2021 Mar; 143(11):1157-1172. PubMed ID: 33720773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Perspectives in Chronic Kidney Disease-Specific Cardiovascular Disease.
    Xu C; Tsihlis G; Chau K; Trinh K; Rogers NM; Julovi SM
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiorenal syndrome: Pathophysiology as a key to the therapeutic approach in an under-diagnosed disease.
    Prastaro M; Nardi E; Paolillo S; Santoro C; Parlati ALM; Gargiulo P; Basile C; Buonocore D; Esposito G; Filardi PP
    J Clin Ultrasound; 2022 Oct; 50(8):1110-1124. PubMed ID: 36218199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [PATHOPHYSIOLOGY OF THE CARDIORENAL SYNDROME].
    Balint I; Vučak J; Bašić-Marković N; Klarić D; Šakić VA
    Acta Med Croatica; 2016 Dec; 70(4-5):325-31. PubMed ID: 29087629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic kidney disease and cardiovascular complications.
    Di Lullo L; House A; Gorini A; Santoboni A; Russo D; Ronco C
    Heart Fail Rev; 2015 May; 20(3):259-72. PubMed ID: 25344016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart functional and structural compendium of cardiosplenic and cardiorenal networks in acute and chronic heart failure pathology.
    Halade GV; Kain V; Ingle KA
    Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H255-H267. PubMed ID: 29101178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incident Hospitalization with Major Cardiovascular Diseases and Subsequent Risk of ESKD: Implications for Cardiorenal Syndrome.
    Ishigami J; Cowan LT; Demmer RT; Grams ME; Lutsey PL; Carrero JJ; Coresh J; Matsushita K
    J Am Soc Nephrol; 2020 Feb; 31(2):405-414. PubMed ID: 31919105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cardiorenal syndrome in heart failure: cardiac? renal? syndrome?
    Triposkiadis F; Starling RC; Boudoulas H; Giamouzis G; Butler J
    Heart Fail Rev; 2012 May; 17(3):355-66. PubMed ID: 22086438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Bidirectional Association of Chronic Kidney Disease, Type 2 Diabetes, Atherosclerotic Cardiovascular Disease, and Heart Failure: The Cardio-Renal-Metabolic Syndrome.
    Nichols GA; Amitay EL; Chatterjee S; Steubl D
    Metab Syndr Relat Disord; 2023 Jun; 21(5):261-266. PubMed ID: 37130317
    [No Abstract]   [Full Text] [Related]  

  • 13. Closing gaps in the care of patients with heart-kidney disease: the time is now.
    Rangaswami J
    Rev Cardiovasc Med; 2021 Jun; 22(2):257-258. PubMed ID: 34258890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of hypoxia-sensing pathways promotes renal ischemic preconditioning following myocardial infarction.
    Terker AS; Sasaki K; Arroyo JP; Niu A; Wang S; Fan X; Zhang Y; Nwosisi S; Zhang MZ; Harris RC
    Am J Physiol Renal Physiol; 2021 Apr; 320(4):F569-F577. PubMed ID: 33522414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular Consequences of Uremic Metabolites: an Overview of the Involved Signaling Pathways.
    Curaj A; Vanholder R; Loscalzo J; Quach K; Wu Z; Jankowski V; Jankowski J
    Circ Res; 2024 Mar; 134(5):592-613. PubMed ID: 38422175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
    Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
    Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TWEAK-Fn14 as a common pathway in the heart and the kidneys in cardiorenal syndrome.
    Poveda J; Vázquez-Sánchez S; Sanz AB; Ortiz A; Ruilope LM; Ruiz-Hurtado G
    J Pathol; 2021 May; 254(1):5-19. PubMed ID: 33512736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cardiorenal Axis: Myocardial Perfusion, Metabolism, and Innervation.
    Shirani J; Meera S; Dilsizian V
    Curr Cardiol Rep; 2019 May; 21(7):60. PubMed ID: 31111315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiorenal syndrome: review of our current understanding.
    Hadjiphilippou S; Kon SP
    J R Soc Med; 2016 Jan; 109(1):12-7. PubMed ID: 26609123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiorenal Syndrome: The Role of Neural Connections Between the Heart and the Kidneys.
    Patel KP; Katsurada K; Zheng H
    Circ Res; 2022 May; 130(10):1601-1617. PubMed ID: 35549375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.